Search, analyze & compare
My selected companies
Adjust valuation method
![]()
Detail of Ginkgo Bioworks Holdings, Inc.
CEO
Dr. Jason Kelly Ph.D.
Employees
1218
Industry
Biotechnology
Sector
Healthcare
Market cap
$15B
Company details
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
Revenue
Cost of goods
Gross profit
OE
R&D
G&A
OI
OIE
PI
TAX
NI
Revenue (Rev)
$217.11M
Cost of goods (CoG)
-$41.54M
Gross profit (GP)
$175.57M
Operating expense (OE)
-$742.81M
Research and development (R&D)
-$464.72M
General and administrative (G&A)
-$278.09M
Operating income (OI)
-$567.24M
Other income expense (OIE)
-$128.79M
Pretax income (PI)
-$651.54M
Tax (TAX)
$352,000.00
Net income (NI)
-$651.19M
Stock vs Industry average
-
Industry average
Negative values are hidden from the graph.
Trailing annual dividend rate
$0.00
Payout ratio
0.00%
EPS
-$17.18
Margin profit
-298.78%
52 week low
$0.222
52 week high
$9.422
50-day simple moving average
$0.00
200-day simple moving average
$6.58
Percent held by insiders
6.16%
Percent held by institutions
68.39%
Dividend yield
0.00%
